INMB·45782T105·US·equity·Healthcare - Biotechnology-13D/G
INMB (INMUNE BIO INC) is held by 51 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($559,464), STATE STREET CORP ($328,693). Net institutional sentiment: Mixed.
See how INMB's score breaks down across 4 SEC sources
Showing 1-20 of 58
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer